Five years after the prominent developer upped its business ambitions—going from a home-renovation firm to high-end, multi-home projects—the firm is unraveling.
An Indianapolis private school is well on its way to reaching a $7 million fundraising goal that will help it unify its campus, thanks to a $1.5 million lead donation from Telamon Corp. CEO Stanley Chen and his wife, Allison.
Gov. Eric Holcomb is leaving for China on Sunday for a two-week-long Asian trade mission, convinced he can boost business relationships even though the Trump administration is embroiled in a trade war with that nation.
We hope our Impact Indiana series—which has been packed full of statistics about corporate social responsibility—encourages business leaders to think not just about how encouraging volunteerism or getting involved in social issues can impact the community. It’s also about how such activities can bolster corporate bottom lines.
The trainings are not a response to a specific incident but rather a way of being proactive, Deputy Mayor Steve Cooke told IBJ. Each day the city sets and enforces a wide range of policies that effect residents.
Vice President Mike Pence stumped for President Trump’s proposed deal with Mexico and Canada during a rally Thursday at McAllister Machinery on the city’s southeast side.
The grant, to be paid over five years, will help the IU School of Medicine launch a drug discovery center as part of a strategic partnership with the Purdue Institute for Drug Discovery at Purdue University.
Former Butler University basketball player Brent Rockwood is set to become vice president and chief of staff at his alma mater, the university said Wednesday.
Twenty-eight potential Hoosiers—some with Indiana connections and others with none—are scouting Indianapolis as part of a TechPoint “red carpet experience” to see if the city is a place they’d like to call home.
The drug, called pegilodecakin, had been seen as a promising treatment for one of the deadliest types of cancer, and was the lead product in Lilly’s $1.6 billion acquisition of Armo BioSciences last year.
Seven months after clinical trials for a promising Alzheimer’s drug were halted and the treatment was declared a failure, a new analysis suggests it was actually effective, and the company that makes it plans to move forward in securing federal approval.
Eli Lilly and Co. easily topped earnings expectations in the third quarter, but shares in the Indianapolis-based drug company tumbled nearly 5 percent Wednesday morning.
Digging through old data to salvage a seemingly failed Alzheimer’s drug paid off big time for Biogen Inc., but at least one of its rivals has no plans to follow suit.
Kristin Sherman joined VMS as CFO in 2016, and a year later added oversight of all the firm’s support functions—everything from legal and IT to compliance and HR.
University research budgets and federal funding levels are seen as increasingly important drivers of economic development as they give rise to more licensed technology and startup companies.
New rules from the Trump administration would require insurers and hospitals to disclose upfront the actual prices for common tests and procedures. The sweeping changes face stiff pushback from the health care industry and could be challenged in court.
The pharmaceutical giant says it needs additional manufacturing capacity to keep up with demand for current medicines and new drugs expected to emerge from its pipeline.
